Latest PLoS Pathogens Stories
Although untreated HIV infection eventually results in immunodeficiency (AIDS), a small group of people infected with the virus, called elite suppressors (0.5 percent of all HIV-infected individuals), are naturally able to control infection in the absence of antiretroviral therapy, or HAART.
Scientists have identified the gene that allows the Rubella virus to block cell death and reverse engineered a mutant gene that slows the virus's spread.
Scientists have demonstrated that stopping the ability of methicillin-resistant Staphylcoccus aureus (MRSA) to degrade RNA can inhibit its spread, both in the laboratory and in infected mice.
Scientists have discovered a new way to attack dangerous pathogens, marking a hopeful next step in the ever-escalating battle between man and microbe.
New findings are bringing scientists closer to an effective HIV vaccine.
Scientists at the University of Zurich (Switzerland) and the Federal Research Institute for Animal Health (FLI; Tuebingen) have challenged the notion that airborne prions are innocuous.
For the first time, researchers have developed a 3D picture of a herpes virus protein interacting with a key part of the human cellular machinery, enhancing our understanding of how it hijacks human cells to spread infection and opening up new possibilities for stepping in to prevent or treat infection.
Study sheds light on what E coli genes are doing inside the body during infection.
Dramatic advance in understanding of how the body fights bacteria paves way for more effective vaccines.
Dr. Ã‰ric A. Cohen, Director of the Human Retrovirology research unit at the Institut de recherches cliniques de MontrÃ©al (IRCM), and his team published yesterday, in the online open-access journal PLos Pathogens, the results of their most recent research on the role of the Vpr protein in HIV (human immunodeficiency virus) infection and AIDS (acquired autoimmune deficiency syndrome).
- Growing in low tufty patches.